£1.08m
vs Feb 2025Active15472206Private limited companyLondon
EMBED BIOTECH LIMITED
Significant control: Thomas Ainsley Grant Hall (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Embed Biotech Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Embed Biotech Limited sell?
Registered activity: Manufacture of irradiation, electromedical and electrotherapeutic equipment (SIC 26600). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EMBED BIOTECH LIMITED is an active private limited company (company number 15472206) incorporated on 7 February 2024, registered in London. Its registered activity is manufacture of irradiation, electromedical and electrotherapeutic equipment (SIC 26600). Latest small accounts cover the period ending 28 February 2026, showing net assets of £1.08m and cash of £1.07m, with 5 employees on average. Net assets rose 11162% on the prior period (−£9,799).
Peer position · net assets
By net assets it sits in the top quarter of 134 comparable companies in the UK (median £1,000, upper quartile £91k).
02
Ownership and control
- Dr Thomas Ainsley Grant Hall
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 February 20242 yrs ago
- Next accounts due
- 28 November 2027in 400 days
- Confirmation statement due
- 21 February 2027in 120 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 26600
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£1.07m
+25083%vs Feb 2025Not reported
5
vs Feb 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2026 | £1.08m | £1.07m | £28k | £28k | — | — | 5 |
| 28 February 2025 | −£9,799 | £4,251 | £1,820 | £16k | — | — | 0 |
Current ratio39.53Current assets ÷ creditors within one year
Cash per employee£214kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,084,010 at 28 February 2026
- Net assets up 10% or more on the prior period+11162.5% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 39.53
- Cash at bank of £50,000 or moreCash £1,070,513
- Incorporated two to five years agoIncorporated 7 February 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 400 days
- Confirmation statement duein 120 days
- Accounts period endNet assets £1.08m · small accounts
- Accounts period endNet liabilities £9,799 · small accounts
- Incorporated
08
Similar companies in London
09
Reminders for EMBED BIOTECH LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.